Optiscan was recently featured on Stockhead’s Vital Signs podcast, where CEO Dr. Camile Farah shared insights into the company’s mission to transform pathology through digital innovation.

At the centre of the conversation was InForm™, Optiscan’s first-in-class digital pathology device that enables immediate, high-resolution imaging of tissue samples—without the need for traditional slide processing.

Built for true end-to-end digitalisation, InForm™ replaces analogue steps with instant digital acquisition, streamlining the workflow from tissue to report. The device has the potential to replace frozen sections, reduce turnaround times, and alleviate pressure on overburdened pathology labs—all while supporting remote collaboration and future AI integration.

Dr. Farah also discussed Optiscan’s broader pipeline, including developments in surgical imaging, GI endoscopy, veterinary applications, and telepathology.

Listen to the full interview here.